Windlas Biotech Ltd. benchmarking: Perfomance to industry peers

Financial

	Windlas Biotech	TTK Healthcare	Beta Drugs
Operational Metrics
Financials
5 yr Average ROE	10.64 %	21.89 %	22.74 %
5yr average Equity Multiplier	1.39	1.39	1.82
5yr Average Asset Turnover Ratio	1.07	0.79	1.03
5yr Avg Net Profit Margin	7.49 %	24.69 %	12.23 %
Price to Book	2.96	1.39	8.35
P/E	23.48	22.73	38.81
5yr Avg Cash Conversion Cycle	-12.87 Days	-18.91 Days	7.75 Days
Inventory Days	39.91 Days	45.37 Days	46.07 Days
Days Receivable	72.81 Days	39.11 Days	91.57 Days
Days Payable	93.99 Days	124.35 Days	119.03 Days
5yr Average Interest Coverage Ratio	42.87	20.16	14.42
5yr Avg ROCE	16.39 %	7.51 %	27.84 %
5yr Avg Operating Profit Margin	12.11 %	4.27 %	21.76 %
5 yr average Debt to Equity	0.05	0.04	0.29
5yr CAGR Net Profit	30.97 %	11.95 %	29.34 %
5yr Average Return on Assets	7.71 %	16.71 %	12.69 %
Shareholdings
Promoter Holding	61.99 %	74.56 %	66.73 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	2.04 %	0.0	0.02 %
Change in Mutual Fund Holding (3 Yrs)	-4.5 %	-2.21 %	0.0

	Windlas Biotech	TTK Healthcare	Beta Drugs
Product Wise Break-Up	Product Wise Break-Up CDMO 72.07 Trade Generics & OTC 23.42 Exports 4.5 Pappads 0 Condoms 0 Ayurvedic Medicines 0 Allopathic Medicines 0 Deodorants 0 Manufacturing of Oncology medicines 0 Others 0.01	Product Wise Break-Up Manufacturing of Oncology medicines 0 Ayurvedic Medicines 19.0 Pappads 14.0 Trade Generics & OTC 0 CDMO 0 Condoms 16.0 Allopathic Medicines 19.0 Deodorants 9.88 Exports 0 Others 22.12	Product Wise Break-Up Oncology 100.0 Ayurvedic Medicines 0 Pappads 0 Trade Generics & OTC 0 CDMO 0 Condoms 0 Allopathic Medicines 0 Deodorants 0 Exports 0
Location Wise Break-Up	Location Wise Break-Up India 95.68 Rest of the World 0 India 0 Others 4.32	Location Wise Break-Up India 89.34 Rest of the World 10.66	Location Wise Break-Up India 0 Rest of the World 0 Others 100
Acute vs Chronic	Acute vs Chronic Chronic & Sub-Chronic 59.0 Acute 41.0	-	-
Segment Wise Break-Up	Segment Wise Break-Up Pharmaceutical 100.0	-	-